A

Predictive functional assay‐based classification of PMS2 variants in Lynch syndrome

Human Mutation, vol. 43, pp. 1249–1258

Abstract

The large majority of germline alterations identified in the DNA mismatch repair (MMR) gene PMS2, a low-penetrance gene for the cancer predisposition Lynch syndrome, represent variants of uncertain significance (VUS). The inability to classify most VUS interferes with personalized healthcare. The complete in vitro MMR activity (CIMRA) assay, that only requires sequence information on the VUS, provides a functional analysis-based quantitative tool to improve the classification of VUS in MMR proteins. To derive a formula that translates CIMRA assay results into the odds of pathogenicity (OddsPath) for VUS in PMS2 we used a set of clinically classified PMS2 variants supplemented by inactivating variants that were generated by an in cellulo genetic screen, as proxies for cancer-predisposing variants. Validation of this OddsPath revealed high predictive values for benign and predisposing PMS2 VUS. We conclude that the OddsPath provides an integral metric that, following the other, higher penetrance, MMR proteins MSH2, MSH6 and MLH1 can be incorporated as strong evidence type into the upcoming criteria for MMR gene VUS classification of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP).

Authors 8

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics Leiden University Medical Center Leiden the Netherlands

    Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

  2. Leiden University Medical Center · Princess Máxima Center

    Affiliation as printed

    Department of Human Genetics Leiden University Medical Center Leiden the Netherlands

    Princess Maxima Center for Child Oncology Utrecht the Netherlands

    Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

    Princess Maxima Center for Child Oncology, Utrecht, the Netherlands

  3. QIMR Berghofer Medical Research Institute

    Affiliation as printed

    QIMR Berghofer Medical Research Institute Brisbane Queensland Australia

    QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  4. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics Leiden University Medical Center Leiden the Netherlands

    Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

  5. Leiden University Medical Center · Erasmus MC

    Affiliation as printed

    Department of Clinical Genetics Erasmus Medical Center Rotterdam the Netherlands

    Department of Human Genetics Leiden University Medical Center Leiden the Netherlands

    Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands

    Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

  6. The Royal Melbourne Hospital

    Affiliation as printed

    Department of Pathology Royal Melbourne Hospital Parkville Victoria Australia

    Department of Pathology, Royal Melbourne Hospital, Parkville, Victoria, Australia

  7. QIMR Berghofer Medical Research Institute

    Affiliation as printed

    QIMR Berghofer Medical Research Institute Brisbane Queensland Australia

    QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

  8. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics Leiden University Medical Center Leiden the Netherlands

    Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

Cited by 11 stored of 11

11 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 23